Formation of a Unique Cluster of G-Quadruplex Structures in the HIV-1 nef Coding Region: Implications for Antiviral Activity

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Perrone, Rosalba ^a   Nadai, Matteo ^a   Poe, Jerrod A ^b   Frasson, Ilaria ^a   Palumbo, Manlio ^a   Palù, Giorgio ^a   Smithgall, Thomas E ^b   Richter, Sara N ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE QUADRUPLEX; LIGAND; NEF PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROMOTER REGION; REPORTER GENE; TELOMERE; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS STRAIN;

GC RICH SEQUENCE; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HIV INFECTIONS; HIV-1; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 84883166324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073121     Document Type: Article

References (73)

1. Brooks TA, Kendrick S, Hurley L, (2010) Making sense of G-quadruplex and i-motif functions in oncogene promoters. FEBS J 277: 3459-3469. doi:10.1111/j.1742-4658.2010.07759.x. PubMed: 20670278.
2. Paeschke K, Simonsson T, Postberg J, Rhodes D, Lipps HJ, (2005) Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo. Nat Struct Mol Biol 12: 847-854. doi:10.1038/nsmb982. PubMed: 16142245.
3. Folini M, Venturini L, Cimino-Reale G, Zaffaroni N, (2011) Telomeres as targets for anticancer therapies. Expert Opin Ther Targets 15: 579-593. PubMed: 21288186.
4. Huppert JL, Balasubramanian S, (2007) G-quadruplexes in promoters throughout the human genome. Nucleic Acids Res 35: 406-413. PubMed: 17169996.
5. Balasubramanian S, Hurley LH, Neidle S, (2011) Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nat Rev Drug Discov 10: 261-275. doi:10.1038/nrd3428. PubMed: 21455236.
6. Weitzmann MN, Woodford KJ, Usdin K, (1997) DNA secondary structures and the evolution of hypervariable tandem arrays. J Biol Chem 272: 9517-9523. doi:10.1074/jbc.272.14.9517. PubMed: 9083093.
7. Dunnick W, Hertz GZ, Scappino L, Gritzmacher C, (1993) DNA sequences at immunoglobulin switch region recombination sites. Nucleic Acids Res 21: 365-372. doi:10.1093/nar/21.3.365. PubMed: 8441648.
8. Hanakahi LA, Sun H, Maizels N, (1999) High affinity interactions of nucleolin with G-G-paired rDNA. J Biol Chem 274: 15908-15912. doi:10.1074/jbc.274.22.15908. PubMed: 10336496.
9. Law MJ, Lower KM, Voon HP, Hughes JR, Garrick D, et al. (2011) ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell 143: 367-378.
10. Maizels N, (2006) Dynamic roles for G4 DNA in the biology of eukaryotic cells. Nat Struct Mol Biol 13: 1055-1059. doi:10.1038/nsmb1171. PubMed: 17146462.
11. Lopes J, Piazza A, Bermejo R, Kriegsman B, Colosio A, et al. (2011) G-quadruplex-induced instability during leading-strand replication. EMBO J 30: 4033-4046. doi:10.1038/emboj.2011.316. PubMed: 21873979.
12. Nambiar M, Goldsmith G, Moorthy BT, Lieber MR, Joshi MV, et al. (2010) Formation of a G-quadruplex at the BCL2 major breakpoint region of the t(14;18) translocation in follicular lymphoma. Nucleic Acids Res 39: 936-948. PubMed: 20880994.
13. Belotserkovskii BP, Liu R, Tornaletti S, Krasilnikova MM, Mirkin SM, et al. (2010) Mechanisms and implications of transcription blockage by guanine-rich DNA sequences. Proc Natl Acad Sci U S A 107: 12816-12821. doi:10.1073/pnas.1007580107. PubMed: 20616059.
14. Duquette ML, Handa P, Vincent JA, Taylor AF, Maizels N, (2004) Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. Genes Dev 18: 1618-1629. doi:10.1101/gad.1200804. PubMed: 15231739.
15. Baral A, Kumar P, Halder R, Mani P, Yadav VK, et al. (2012) Quadruplex-single nucleotide polymorphisms (Quad-SNP) influence gene expression difference among individuals. Nucleic Acids Res 40: 3800-3811. doi:10.1093/nar/gkr1258. PubMed: 22238381.
16. Biffi G, Tannahill D, McCafferty J, Balasubramanian S, (2013) Quantitative visualization of DNA G-quadruplex structures in human cells. Nat Chem 5: 182-186. doi:10.1038/nchempp. 1548. PubMed: 23422559.
17. Ou TM, Lu YJ, Tan JH, Huang ZS, Wong KY, et al. (2008) G-quadruplexes: targets in anticancer drug design. Chemmedchem 3: 690-713. doi:10.1002/cmdc.200700300. PubMed: 18236491.
18. Fedoroff OY, Salazar M, Han H, Chemeris VV, Kerwin SM, et al. (1998) NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry 37: 12367-12374. doi:10.1021/bi981330n. PubMed: 9730808.
19. Izbicka E, Wheelhouse RT, Raymond E, Davidson KK, Lawrence RA, et al. (1999) Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res 59: 639-644. PubMed: 9973212.
20. Campbell NH, Parkinson GN, Reszka AP, Neidle S, (2008) Structural basis of DNA quadruplex recognition by an acridine drug. J Am Chem Soc 130: 6722-6724. doi:10.1021/ja8016973. PubMed: 18457389.
21. Kim MY, Vankayalapati H, Shin-Ya K, Wierzba K, Hurley LH, (2002) Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex. J Am Chem Soc 124: 2098-2099. doi:10.1021/ja017308q. PubMed: 11878947.
22. Drygin D, Siddiqui-Jain A, O'Brien S, Schwaebe M, Lin A, et al. (2009) Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res 69: 7653-7661. doi:10.1158/0008-5472.CAN-09-1304. PubMed: 19738048.
23. Wieland M, Hartig JS, (2009) Investigation of mRNA quadruplex formation in Escherichia coli. Nat Protoc 4: 1632-1640. doi:10.1038/nprot.2009.111. PubMed: 19876023.
24. Beaume N, Pathak R, Yadav VK, Kota S, Misra HS, et al. (2013) Genome-wide study predicts promoter-G4 DNA motifs regulate selective functions in bacteria: radioresistance of D. radiodurans involves G4 DNA-mediated regulation. Nucleic Acids Res 41: 76-89. doi:10.1093/nar/gkt004. PubMed: 23161683.
25. Rawal P, Kummarasetti VB, Ravindran J, Kumar N, Halder K, et al. (2006) Genome-wide prediction of G4 DNA as regulatory motifs: role in Escherichia coli global regulation. Genome Res 16: 644-655. doi:10.1101/gr.4508806. PubMed: 16651665.
26. Gallo RC, Montagnier L, (2003) The discovery of HIV as the cause of AIDS. N Engl J Med 349: 2283-2285. doi:10.1056/NEJMp038194. PubMed: 14668451.
27. AIDSinfo (2011) HIV and Its Treatment- FDA-Approved Anti-HIV Medications. In: Services DoHaH, editor: U.S. Department of Health and Human Services' Guidelines.
28. Hemelaar J, Gouws E, Ghys PD, Osmanov S, (2011) Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25: 679-689. doi:10.1097/QAD.0b013e328342ff93. PubMed: 21297424.
29. Kuiken C, Leitner T, Foley B, Hahn B, Marx P, et al. (2008) HIV Sequence Compendium 2008. Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, New Mexico. LaUR: pp. 08-03719.
30. Miller MD, Warmerdam MT, Gaston I, Greene WC, Feinberg MB, (1994) The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 179: 101-113. doi:10.1084/jem.179.1.101. PubMed: 8270859.
31. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, Richman DD, (1994) The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med 179: 115-123. doi:10.1084/jem.179.1.115. PubMed: 7903679.
32. Harris M, (1999) HIV: a new role for Nef in the spread of HIV. Curr Biol 9: R459-R461. doi:10.1016/S0960-9822(99)80282-6. PubMed: 10375524.
33. Aiken C, Trono D, (1995) Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J Virol 69: 5048-5056. PubMed: 7541845.
34. Salvi R, Garbuglia AR, Di Caro A, Pulciani S, Montella F, et al. (1998) Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor. J Virol 72: 3646-3657. PubMed: 9557645.
35. Kestler HW 3rd, Ringler DJ, Mori K, Panicali DL, Sehgal PK, et al. (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65: 651-662. doi:10.1016/0092-8674(91)90097-I. PubMed: 2032289.
36. Richter SN, Frasson I, Palù G, (2009) Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy? Curr Med Chem 16: 267-286. doi:10.2174/092986709787002646. PubMed: 19149577.
37. Lyonnais S, Gorelick RJ, Mergny JL, Le Cam E, Mirambeau G, (2003) G-quartets direct assembly of HIV-1 nucleocapsid protein along single-stranded DNA. Nucleic Acids Res 31: 5754-5763. doi:10.1093/nar/gkg716. PubMed: 14500839.
38. Sundquist WI, Heaphy S, (1993) Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA. Proc Natl Acad Sci U S A 90: 3393-3397. doi:10.1073/pnas.90.8.3393. PubMed: 8475087.
39. Kikin O, D'Antonio L, Bagga PS, (2006) QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res 34: W676-W682. doi:10.1093/nar/gkj467. PubMed: 16845096.
40. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D, (1998) Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 72: 2855-2864. PubMed: 9525605.
41. Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O'Brien WA, et al. (2000) Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol 74: 8358-8367. doi:10.1128/JVI.74.18.8358-8367.2000. PubMed: 10954535.
42. Emert-Sedlak L, Kodama T, Lerner EC, Dai W, Foster C, et al. (2009) Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds. ACS Chem Biol 4: 939-947. doi:10.1021/cb900195c. PubMed: 19807124.
43. Narute PS, Smithgall TE, (2012) Nef alleles from all major HIV-1 clades activate Src-family kinases and enhance HIV-1 replication in an inhibitor-sensitive manner. PLOS ONE 7: e32561. doi:10.1371/journal.pone.0032561. PubMed: 22393415.
44. Poe JA, Smithgall TE, (2009) HIV-1 Nef dimerization is required for Nef-mediated receptor downregulation and viral replication. J Mol Biol 394: 329-342. doi:10.1016/j.jmb.2009.09.047. PubMed: 19781555.
45. Emert-Sedlak LA, Narute P, Shu ST, Poe JA, Shi H, et al. (2013) Effector kinase coupling enables high-throughput screens for direct HIV-1 Nef antagonists with antiretroviral activity. Chem Biol 20: 82-91. doi:10.1016/j.chembiol.2012.11.005. PubMed: 23352142.
46. Grzesiek S, Bax A, Clore GM, Gronenborn AM, Hu JS, et al. (1996) The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat Struct Biol 3: 340-345. doi:10.1038/nsb0496-340. PubMed: 8599760.
47. Lee CH, Saksela K, Mirza UA, Chait BT, Kuriyan J, (1996) Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85: 931-942. doi:10.1016/S0092-8674(00)81276-3. PubMed: 8681387.
48. Cheng H, Hoxie JP, Parks WP, (1999) The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes. Virology 264: 5-15. doi:10.1006/viro.1999.9937. PubMed: 10544125.
49. Bouaziz S, Kettani A, Patel DJ, (1998) A K cation-induced conformational switch within a loop spanning segment of a DNA quadruplex containing G-G-G-C repeats. J Mol Biol 282: 637-652. doi:10.1006/jmbi.1998.2031. PubMed: 9737927.
50. Vorlickova M, Kejnovska I, Sagi J, Renciuk D, Bednarova K, et al. (2012) Circular dichroism and guanine quadruplexes. Methods.
51. Guédin A, Gros J, Alberti P, Mergny JL, (2010) How long is too long? Effects of loop size on G-quadruplex stability. Nucleic Acids Res 38: 7858-7868. doi:10.1093/nar/gkq639. PubMed: 20660477.
52. Kypr J, Kejnovská I, Renciuk D, Vorlícková M, (2009) Circular dichroism and conformational polymorphism of DNA. Nucleic Acids Res 37: 1713-1725. doi:10.1093/nar/gkp026. PubMed: 19190094.
53. Morris MJ, Wingate KL, Silwal J, Leeper TC, Basu S, (2012) The porphyrin TmPyP4 unfolds the extremely stable G-quadruplex in MT3-MMP mRNA and alleviates its repressive effect to enhance translation in eukaryotic cells. Nucleic Acids Res, 40: 4137-45. PubMed: 22266651.
54. Palumbo SL, Ebbinghaus SW, Hurley LH, (2009) Formation of a unique end-to-end stacked pair of G-quadruplexes in the hTERT core promoter with implications for inhibition of telomerase by G-quadruplex-interactive ligands. J Am Chem Soc 131: 10878-10891. doi:10.1021/ja902281d. PubMed: 19601575.
55. Han H, Langley DR, Rangan A, Hurley LH, (2001) Selective interactions of cationic porphyrins with G-quadruplex structures. J Am Chem Soc 123: 8902-8913. doi:10.1021/ja002179j. PubMed: 11552797.
56. Chowers MY, Spina CA, Kwoh TJ, Fitch NJ, Richman DD, et al. (1994) Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol 68: 2906-2914. PubMed: 8151761.
57. Vermeire J, Vanbillemont G, Witkowski W, Verhasselt B, (2011) The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection. Curr HIV Res 9: 474-489. doi:10.2174/157016211798842099. PubMed: 22103831.
58. Sun D, Hurley LH, (2009) The importance of negative superhelicity in inducing the formation of G-quadruplex and i-motif structures in the c-Myc promoter: implications for drug targeting and control of gene expression. J Med Chem 52: 2863-2874. doi:10.1021/jm900055s. PubMed: 19385599.
59. Raiber EA, Kranaster R, Lam E, Nikan M, Balasubramanian S, (2012) A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro. Nucleic Acids Res 40: 1499-1508. doi:10.1093/nar/gkr882. PubMed: 22021377.
60. Basundra R, Kumar A, Amrane S, Verma A, Phan AT, et al. (2010) A novel G-quadruplex motif modulates promoter activity of human thymidine kinase 1. FEBS J 277: 4254-4264. doi:10.1111/j.1742-4658.2010.07814.x. PubMed: 20849417.
61. Jang MY, Yarborough OH 3rd, Conyers GB, McPhie P, Owens RA, (2005) Stable secondary structure near the nicking site for adeno-associated virus type 2 Rep proteins on human chromosome 19. J Virol 79: 3544-3556. doi:10.1128/JVI.79.6.3544-3556.2005. PubMed: 15731249.
62. Kettani A, Bouaziz S, Wang W, Jones RA, Patel DJ, (1997) Bombyx mori single repeat telomeric DNA sequence forms a G-quadruplex capped by base triads. Nat Struct Biol 4: 382-389. doi:10.1038/nsb0597-382. PubMed: 9145109.
63. Xu Y, Sugiyama H, (2006) Formation of the G-quadruplex and i-motif structures in retinoblastoma susceptibility genes (Rb). Nucleic Acids Res 34: 949-954. doi:10.1093/nar/gkj485. PubMed: 16464825.
64. Hu L, Lim KW, Bouaziz S, Phan AT, (2009) Giardia telomeric sequence d(TAGGG)4 forms two intramolecular G-quadruplexes in K+ solution: effect of loop length and sequence on the folding topology. J Am Chem Soc 131: 16824-16831. doi:10.1021/ja905611c. PubMed: 19874015.
65. Lim KW, Alberti P, Guédin A, Lacroix L, Riou JF, et al. (2009) Sequence variant (CTAGGG)n in the human telomere favors a G-quadruplex structure containing a G.C.G.C tetrad. Nucleic Acids Res 37: 6239-6248. doi:10.1093/nar/gkp630. PubMed: 19692585.
66. Lim KW, Amrane S, Bouaziz S, Xu W, Mu Y, et al. (2009) Structure of the human telomere in K+ solution: a stable basket-type G-quadruplex with only two G-tetrad layers. J Am Chem Soc 131: 4301-4309. doi:10.1021/ja807503g. PubMed: 19271707.
67. Phan AT, (2010) Human telomeric G-quadruplex: structures of DNA and RNA sequences. FEBS J 277: 1107-1117. doi:10.1111/j.1742-4658.2009.07464.x. PubMed: 19951353.
68. Mullen MA, Assmann SM, Bevilacqua PC, (2012) Toward a digital gene response: RNA G-quadruplexes with fewer quartets fold with higher cooperativity. J Am Chem Soc 134: 812-815. doi:10.1021/ja2096255. PubMed: 22239732.
69. Zhang AY, Bugaut A, Balasubramanian S, (2011) A sequence-independent analysis of the loop length dependence of intramolecular RNA G-quadruplex stability and topology. Biochemistry 50: 7251-7258. doi:10.1021/bi200805j. PubMed: 21744844.
70. Neidle S, (2010) Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS J 277: 1118-1125. doi:10.1111/j.1742-4658.2009.07463.x. PubMed: 19951354.
71. De Cian A, Lacroix L, Douarre C, Temime-Smaali N, Trentesaux C, et al. (2008) Targeting telomeres and telomerase. Biochimie 90: 131-155. doi:10.1016/j.biochi.2007.07.011. PubMed: 17822826.
72. Neidle S, (2009) The structures of quadruplex nucleic acids and their drug complexes. Curr Opin Struct Biol 19: 239-250. doi:10.1016/j.sbi.2009.04.001. PubMed: 19487118.
73. Geyer M, Fackler OT, Peterlin BM, (2001) Structure--function relationships in HIV-1 Nef. EMBO Rep 2: 580-585. doi:10.1093/embo-reports/kve141. PubMed: 11463741.